Viewing Study NCT07275060


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 3:24 AM
Study NCT ID: NCT07275060
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2025-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart
Sponsor: Canadian Immunization Research Network
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module